Litigation Details for Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited (D. Del. 2015)
✉ Email this page to a colleague
Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited (D. Del. 2015)
| Docket | ⤷ Sign Up | Date Filed | 2015-10-13 |
| Court | District Court, D. Delaware | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | None | Referred To | |
| Patents | 8,586,610; 9,138,432 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Vanda Pharmaceuticals Inc. v. West-Ward Pharmaceuticals International Limited (D. Del. 2015)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2015-10-13 | 1 | infringement of a patent in the same family as the ’432 patent, namely U.S. Patent No. 8,586,610 (“the ’610….S. Patent No. RE39,198 (the ’198 patent). Because the ’198 patent expires before the ’432 patent will…infringement of claim 1 of Vanda’s U.S. Patent No. 9,138,432 (“the ’432 patent”), which relates to the field of…the ’432 patent, or any extensions thereof. Roxane will infringe claim 1 of the ’432 patent under 35 … to the methods of the ’432 patent prior to the expiration of that patent, or any extensions thereof. | External link to document | |
| 2022-09-14 | 105 | Judgment - Consent | WHEREAS, Vanda owns United States Patent No. 9,138,432 (“the *432 patent’). WHEREAS, Hikma submitted Abbreviated…infringing the ’432 patent. WHEREAS, in this Action, Hikma has denied that the ’432 patent is valid, enforceable…for infringement of the ’432 patent. 3. Hikma acknowledges that ’432 patent is valid and enforceable, as…alleges that Hikma infringed claim 1 of the °432 patent under 35 U.S.C. § 271(e)(2) by virtue of Hikma’…contributing to infringement of claim 1 of the ’432 patent. WHEREAS, in this Action, Vanda requested that | External link to document |
| 2016-10-05 | 33 | Plaintiffs (Nos. 1-14) directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00919 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-10-10 | 35 | Plaintiffs (Nos. 15-20) Directed to U.S. Patent No. 9,138,432 filed by Taro Pharmaceutical Industries,… 13 October 2015 1:15-cv-00919 830 Patent None District Court, D. Delaware | External link to document | |
| 0000-00-00 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,138,432. (sec) (Entered: 10… 13 October 2015 1:15-cv-00919 830 Patent None District Court, D. Delaware | External link to document | |
| 2016-11-04 | 45 | Interrogatories to Vanda (Nos. 1-16) Directed To U.S. Patent No. 8,586,610 filed by Vanda Pharmaceuticals Inc..(Fahnestock…Interrogatories to Vanda (Nos. 1-14) Directed to U.S. Patent No. 9,138,432 and (2) Vanda's Objections and Responses… 13 October 2015 1:15-cv-00919 830 Patent None District Court, D. Delaware | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
